ChemExpressRetatrutide
Ordered Retatrutide from ChemExpress? Mail in a sample (US only) and let us test it.
Test my supplyChemExpress Retatrutide has a mixed, sparse evidence profile under the purity-focus method. An Oct identity failure was followed by a Nov pass at 99.99% purity and -2% fill, so the rating reflects volatility, not a steady record.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including ChemExpress rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 9 Nov 2026 | Pass | 735tvyu Tested | lab name | View COA | |||
| 21 Oct 2026 | Fail | ey5czne Tested | lab name | View COA | |||
About ChemExpress test results from Finnrick
ChemExpress is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 2 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible ChemExpress peptides in this dataset are Retatrutide (2 tests), Cagrilintide (0 tests) and GHK-Cu (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 2 recent tests.
Ordered Retatrutide from ChemExpress? Mail in a sample (US only) and let us test it.
Test my supply